Objective Albuterol is a β2‐agonist and causes an intracellular shift of potassium from the interstitium. Whole‐body hypokalemia is known to cause skeletal muscle weakness, but whether this occurs as a result of hypokalemia from the intracellular shift ...
Catherine Burger +2 more
doaj +2 more sources
We describe a case of 13-year-old female with intermittent asthma who developed lactic acidosis and diastolic hypotension after receiving intermittent albuterol nebulizer treatment.
Tehila A. Saadia +2 more
doaj +2 more sources
Efficacy and safety of as-needed albuterol–budesonide versus albuterol in patients with asthma aged 12 to [PDF]
Introduction Asthma among adolescents (aged 12–<18 years) is a common condition with high disease burden. Many are undertreated, at risk of adverse outcomes and exhibit poor adherence to maintenance medication.
Raulin Surujbally +7 more
doaj +2 more sources
Limiting Albuterol Use by EMS at the Start of the COVID-19 Pandemic: A Retrospective Analysis of Rapid Deimplementation [PDF]
Introduction: Deimplementation is the process through which an existing practice, procedure, or protocol is discontinued. Past deimplementation efforts in emergency medical services (EMS), such as reduction of liberal oxygen administration, backboard use,
Renoj Varughese +7 more
doaj +2 more sources
Exhaled Breath Condensate Detects Baseline Reductions in Chloride and Increases in Response to Albuterol in Cystic Fibrosis Patients [PDF]
Impaired ion regulation and dehydration is the primary pathophysiology in cystic fibrosis (CF) lung disease. A potential application of exhaled breath condensate (EBC) collection is to assess airway surface liquid ionic composition at baseline and in ...
Courtney M. Wheatley +7 more
doaj +2 more sources
Albuterol Use in Children Hospitalized with Human Metapneumovirus Respiratory Infection [PDF]
Introduction. Human metapneumovirus (HMPV) is a paramyxovirus from the same subfamily as respiratory syncytial virus (RSV) and causes similar acute lower respiratory tract infection.
Lindsey K. Rasmussen +2 more
doaj +2 more sources
Assessing the cardiovascular and potassium lowering effects of levalbuterol compared to albuterol: a randomized control trial [PDF]
BackgroundBeta-agonists like Levalbuterol and Albuterol are used in the treatment of Hyperkalemia. However, few studies in the medical literature have directly compared the cardiac effects and potassium-lowering efficacy of levalbuterol and albuterol ...
Baraa Shebli +5 more
doaj +2 more sources
Historical cohort study examining comparative effectiveness of albuterol inhalers with and without integrated dose counter for patients with asthma or chronic obstructive pulmonary disease [PDF]
David B Price,1,2 Anna Rigazio,2 Mary Buatti Small,3 Thomas J Ferro,3 1Academic Primary Care, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK; 2Research in Real-Life Ltd, Cambridge, UK; 3Teva Pharmaceuticals, Frazer, PA, USA ...
Price DB +3 more
doaj +3 more sources
A 10-year interval of cardiovascular effects of albuterol in asthma management: Graphical review [PDF]
Asthma is a widespread chronic respiratory disease that requires effective management to reduce exacerbations and improve patient outcomes. Albuterol (salbutamol), a short-acting beta-2-agonist (SABA), remains a mainstay treatment for acute symptom ...
Ghulam H. Abbas +6 more
doaj +2 more sources
Long-acting β2 agonist (LABA) with a long-acting muscarinic receptor antagonist (LAMA) promotes human airway smooth muscle (HASM) relaxation and circumvents β2 adrenergic receptor tachyphylaxis [PDF]
To fill the gap in the knowledge between clinical studies and pre-clinical mechanistic studies using combined LABA/LAMA therapy, we hypothesized that the combination is more effective in attenuating excitation-contraction (E-C) coupling compared to ...
Joseph Jude +5 more
doaj +2 more sources

